Recurrent Transformed B-cell Non-Hodgkin Lymphoma

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB13915	Axicabtagene ciloleucel	1	Not Yet Recruiting	1
DB00531	Cyclophosphamide	1	Not Yet Recruiting	1
DB01073	Fludarabine	1	Not Yet Recruiting	1
DB00531	Cyclophosphamide	1 / 2	Recruiting	1
DB01073	Fludarabine	1 / 2	Recruiting	1
DB12498	Mogamulizumab	1 / 2	Completed	1
DB09037	Pembrolizumab	1 / 2	Completed	1
DB02379	Beta-D-Glucose	2	Active Not Recruiting	1
DB01008	Busulfan	2	Withdrawn	1
DB00958	Carboplatin	2	Active Not Recruiting	1
DB00631	Clofarabine	2	Withdrawn	1
DB00531	Cyclophosphamide	2	Active Not Recruiting	1
DB00531	Cyclophosphamide	2	Recruiting	1
DB00531	Cyclophosphamide	2	Withdrawn	1
DB00773	Etoposide	2	Active Not Recruiting	1
DB01073	Fludarabine	2	Recruiting	1
DB00441	Gemcitabine	2	Withdrawn	1
DB09053	Ibrutinib	2	Completed	1
DB01181	Ifosfamide	2	Active Not Recruiting	1
DB16582	Lisocabtagene maraleucel	2	Recruiting	1
DB00688	Mycophenolate mofetil	2	Withdrawn	1
DB12240	Polatuzumab vedotin	2	Active Not Recruiting	1
DB00073	Rituximab	2	Active Not Recruiting	1
DB00073	Rituximab	2	Withdrawn	1
DB00864	Tacrolimus	2	Withdrawn	1
DB02546	Vorinostat	2	Withdrawn	1
DB15035	Zanubrutinib	2	Recruiting	2